Literature DB >> 7084998

Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.

R K Saxena, Q B Saxena, W H Adler.   

Abstract

Our previous work has shown that antibody-coated mouse spleen cells express enhanced cytotoxic activity against some Fc-receptor-bearing target tumour cells by a mechanism which appears to be similar to an antibody-dependent cell-mediated cytotoxicity (ADCC) reaction with reversed polarity of the antibody bridge (R-ADCC). In this report we have shown that (i) the levels of basal natural killer (NK), ADCC and R-ADCC cytotoxic activities in mouse spleen cells are strongly correlated with each other, (b) simultaneous induction of ADCC and R-ADCC reactions does not result in an additive cytotoxic response, and (iii) YAC cells which do not bear Fc receptors and are highly sensitive to lysis by NK cells, can specifically and competitively inhibit the ADCC and R-ADCC reactions. These results suggest that the R-ADCC reaction may be mediated by the same effector cell population as mediates NK and ADCC reactions against tumour target cells.

Entities:  

Mesh:

Year:  1982        PMID: 7084998      PMCID: PMC1555395     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  7 in total

1.  Target-effector interaction in the natural killer cell system: isolation of target structures.

Authors:  J C Roder; A Rosén; E M Fenyö; F A Troy
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 2.  In vitro and in vivo investigations on antibody-dependent cellular cytotoxicity.

Authors:  G R Pearson
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

3.  Modulation of natural cytotoxicity by alloantibodies. V. The mechanism of a selective augmenting effect of anti-H-2 antisera on the natural killer activity of mouse spleen cells.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Cell Immunol       Date:  1981-11-15       Impact factor: 4.868

4.  Modulation of natural cytotoxicity by alloantibodies. III. Augmentation of natural killer activity by alloantisera directed against K, D, and I regions of the murine H-2 complex.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Cell Immunol       Date:  1980-11       Impact factor: 4.868

5.  Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.

Authors:  R K Saxena; W H Adler
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

6.  Identification of a cell-surface antigen selectively expressed on the natural killer cell.

Authors:  L Glimcher; F W Shen; H Cantor
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

7.  A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity.

Authors:  P Halloran; V Schirrmacher; H Festenstein
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

  7 in total
  5 in total

1.  Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis.

Authors:  M Grazia Cifone; R Giacomelli; G Famularo; R Paolini; C Danese; T Napolitano; A Procopio; A M Perego; A Santoni; G Tonietti
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  Effect of feeding a diet with half of the recommended levels of all vitamins on the natural and inducible levels of cytotoxic activity in mouse spleen cells.

Authors:  Q B Saxena; R K Saxena; W H Adler
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

3.  Role of major histocompatibility complex class I antigens in modulating the performance of murine tumour cells in cold target competition assays.

Authors:  V Haridas; R K Saxena
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

4.  Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

Review 5.  Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats.

Authors:  Brent A Williams; Arjun Law; Judit Hunyadkurti; Stephanie Desilets; Jeffrey V Leyton; Armand Keating
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.